MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

NASDAQ:MNST • US61174X1090

85.3 USD
-1.36 (-1.57%)
At close: Feb 27, 2026
84.78 USD
-0.52 (-0.61%)
Pre-Market: 3/2/2026, 4:42:47 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MNST. MNST was compared to 33 industry peers in the Beverages industry. MNST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MNST is quite expensive at the moment. It does show a decent growth rate. These ratings would make MNST suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year MNST was profitable.
  • MNST had a positive operating cash flow in the past year.
  • Each year in the past 5 years MNST has been profitable.
  • Of the past 5 years MNST 4 years had a positive operating cash flow.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.97%, MNST belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
  • The Return On Equity of MNST (22.30%) is better than 78.79% of its industry peers.
  • With an excellent Return On Invested Capital value of 22.69%, MNST belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MNST is significantly above the industry average of 11.71%.
  • The 3 year average ROIC (21.05%) for MNST is below the current ROIC(22.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.97%
ROE 22.3%
ROIC 22.69%
ROA(3y)18.49%
ROA(5y)17.5%
ROE(3y)22.74%
ROE(5y)21.23%
ROIC(3y)21.05%
ROIC(5y)19.97%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 21.65%, MNST belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MNST has declined.
  • With an excellent Operating Margin value of 29.91%, MNST belongs to the best of the industry, outperforming 96.97% of the companies in the same industry.
  • MNST's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 55.81%, MNST is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • MNST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.91%
PM (TTM) 21.65%
GM 55.81%
OM growth 3Y5.07%
OM growth 5Y-3.96%
PM growth 3Y6.76%
PM growth 5Y-5.6%
GM growth 3Y3.55%
GM growth 5Y-0.65%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • MNST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • MNST has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MNST has been reduced compared to 5 years ago.
  • There is no outstanding debt for MNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • MNST has an Altman-Z score of 30.18. This indicates that MNST is financially healthy and has little risk of bankruptcy at the moment.
  • MNST has a Altman-Z score of 30.18. This is amongst the best in the industry. MNST outperforms 100.00% of its industry peers.
  • There is no outstanding debt for MNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 30.18
ROIC/WACC2.64
WACC8.61%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 3.19 indicates that MNST has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.19, MNST belongs to the best of the industry, outperforming 93.94% of the companies in the same industry.
  • MNST has a Quick Ratio of 2.74. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
  • MNST has a better Quick ratio (2.74) than 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.74
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 27.33% over the past year.
  • MNST shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.12% yearly.
  • Looking at the last year, MNST shows a quite strong growth in Revenue. The Revenue has grown by 10.70% in the last year.
  • Measured over the past years, MNST shows a quite strong growth in Revenue. The Revenue has been growing by 12.52% on average per year.
EPS 1Y (TTM)27.33%
EPS 3Y22.51%
EPS 5Y11.12%
EPS Q2Q%34.21%
Revenue 1Y (TTM)10.7%
Revenue growth 3Y9.54%
Revenue growth 5Y12.52%
Sales Q2Q%17.6%

3.2 Future

  • Based on estimates for the next years, MNST will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.46% on average per year.
  • Based on estimates for the next years, MNST will show a quite strong growth in Revenue. The Revenue will grow by 8.23% on average per year.
EPS Next Y12.62%
EPS Next 2Y12.59%
EPS Next 3Y12.71%
EPS Next 5Y12.46%
Revenue Next Year9.43%
Revenue Next 2Y9.03%
Revenue Next 3Y8.45%
Revenue Next 5Y8.23%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.61, the valuation of MNST can be described as expensive.
  • MNST's Price/Earnings ratio is a bit more expensive when compared to the industry. MNST is more expensive than 63.64% of the companies in the same industry.
  • MNST's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.07.
  • MNST is valuated quite expensively with a Price/Forward Earnings ratio of 36.95.
  • Based on the Price/Forward Earnings ratio, MNST is valued a bit more expensive than 63.64% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, MNST is valued a bit more expensive.
Industry RankSector Rank
PE 41.61
Fwd PE 36.95
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MNST indicates a slightly more expensive valuation: MNST is more expensive than 63.64% of the companies listed in the same industry.
  • MNST's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 41.98
EV/EBITDA 32.35
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of MNST may justify a higher PE ratio.
  • A more expensive valuation may be justified as MNST's earnings are expected to grow with 12.71% in the coming years.
PEG (NY)3.3
PEG (5Y)3.74
EPS Next 2Y12.59%
EPS Next 3Y12.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MNST!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MONSTER BEVERAGE CORP

NASDAQ:MNST (2/27/2026, 8:20:47 PM)

Premarket: 84.78 -0.52 (-0.61%)

85.3

-1.36 (-1.57%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners69.35%
Inst Owner Change-2.33%
Ins Owners0.49%
Ins Owner Change-1.06%
Market Cap83.34B
Revenue(TTM)8.29B
Net Income(TTM)1.73B
Analysts76.77
Price Target81.94 (-3.94%)
Short Float %2.64%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.88%
Min EPS beat(2)4.08%
Max EPS beat(2)13.67%
EPS beat(4)2
Avg EPS beat(4)2.64%
Min EPS beat(4)-6.99%
Max EPS beat(4)13.67%
EPS beat(8)2
Avg EPS beat(8)-2.09%
EPS beat(12)4
Avg EPS beat(12)-1.59%
EPS beat(16)4
Avg EPS beat(16)-3.85%
Revenue beat(2)1
Avg Revenue beat(2)0.92%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)-1.84%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)2.29%
Revenue beat(8)1
Avg Revenue beat(8)-2.96%
Revenue beat(12)1
Avg Revenue beat(12)-3.16%
Revenue beat(16)4
Avg Revenue beat(16)-1.96%
PT rev (1m)5.88%
PT rev (3m)10.93%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)1.61%
EPS NY rev (1m)1.09%
EPS NY rev (3m)5.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)2.66%
Valuation
Industry RankSector Rank
PE 41.61
Fwd PE 36.95
P/S 10.45
P/FCF 41.98
P/OCF 38.22
P/B 10.76
P/tB 16.69
EV/EBITDA 32.35
EPS(TTM)2.05
EY2.4%
EPS(NY)2.31
Fwd EY2.71%
FCF(TTM)2.03
FCFY2.38%
OCF(TTM)2.23
OCFY2.62%
SpS8.16
BVpS7.93
TBVpS5.11
PEG (NY)3.3
PEG (5Y)3.74
Graham Number19.12
Profitability
Industry RankSector Rank
ROA 17.97%
ROE 22.3%
ROCE 29.74%
ROIC 22.69%
ROICexc 33.44%
ROICexgc 67.64%
OM 29.91%
PM (TTM) 21.65%
GM 55.81%
FCFM 24.89%
ROA(3y)18.49%
ROA(5y)17.5%
ROE(3y)22.74%
ROE(5y)21.23%
ROIC(3y)21.05%
ROIC(5y)19.97%
ROICexc(3y)30.55%
ROICexc(5y)30.88%
ROICexgc(3y)63.3%
ROICexgc(5y)70.43%
ROCE(3y)27.59%
ROCE(5y)26.18%
ROICexgc growth 3Y-0.45%
ROICexgc growth 5Y-13.62%
ROICexc growth 3Y6.85%
ROICexc growth 5Y-2.86%
OM growth 3Y5.07%
OM growth 5Y-3.96%
PM growth 3Y6.76%
PM growth 5Y-5.6%
GM growth 3Y3.55%
GM growth 5Y-0.65%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 190.36%
Cap/Sales 2.45%
Interest Coverage 142.32
Cash Conversion 87.65%
Profit Quality 114.95%
Current Ratio 3.19
Quick Ratio 2.74
Altman-Z 30.18
F-Score5
WACC8.61%
ROIC/WACC2.64
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.33%
EPS 3Y22.51%
EPS 5Y11.12%
EPS Q2Q%34.21%
EPS Next Y12.62%
EPS Next 2Y12.59%
EPS Next 3Y12.71%
EPS Next 5Y12.46%
Revenue 1Y (TTM)10.7%
Revenue growth 3Y9.54%
Revenue growth 5Y12.52%
Sales Q2Q%17.6%
Revenue Next Year9.43%
Revenue Next 2Y9.03%
Revenue Next 3Y8.45%
Revenue Next 5Y8.23%
EBIT growth 1Y20.27%
EBIT growth 3Y15.09%
EBIT growth 5Y8.06%
EBIT Next Year16.1%
EBIT Next 3Y11.95%
EBIT Next 5Y10.36%
FCF growth 1Y22.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.69%
OCF growth 3YN/A
OCF growth 5YN/A

MONSTER BEVERAGE CORP / MNST FAQ

What is the ChartMill fundamental rating of MONSTER BEVERAGE CORP (MNST) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MNST.


What is the valuation status of MONSTER BEVERAGE CORP (MNST) stock?

ChartMill assigns a valuation rating of 2 / 10 to MONSTER BEVERAGE CORP (MNST). This can be considered as Overvalued.


What is the profitability of MNST stock?

MONSTER BEVERAGE CORP (MNST) has a profitability rating of 8 / 10.


Can you provide the financial health for MNST stock?

The financial health rating of MONSTER BEVERAGE CORP (MNST) is 9 / 10.


What is the earnings growth outlook for MONSTER BEVERAGE CORP?

The Earnings per Share (EPS) of MONSTER BEVERAGE CORP (MNST) is expected to grow by 12.62% in the next year.